Dr. Mohamad Z. Koubeissi, MD

Dr. Koubeissi practices at The George Washington University Hospital in Washington, District of Columbia, part of Universal Health Services.

Dr. Koubeissi's NPI, 1548368970, was assigned on September 20, 2006. Dr. Koubeissi graduated from American University of Beirut Faculty of Medicine in 1999. Dr. Koubeissi holds District of Columbia license MD040623.

Dr. Koubeissi's primary practice is The George Washington University Hospital, at 900 23rd St NW, Washington, DC 20037 in The District County. The practice phone is (202) 716-4605.

Dr. Koubeissi's primary practice is The George Washington University Hospital in Washington, District of Columbia, part of Universal Health Services. The medical group on file is The GW Medical Faculty Associates. Dmand AI also links Dr. Koubeissi to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Koubeissi practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Koubeissi's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Koubeissi is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Koubeissi's licenses on file in 4 states: District of Columbia, Maryland, Virginia and Ohio.

Dmand AI lists epilepsy, seizures and stroke among the conditions Dr. Koubeissi treats.

CMS data shows 184 Medicare services from Dr. Koubeissi across 5 procedure codes in 2024, for 84 Medicare patients. Medicare paid $17,875 for them.

CMS counts 84 Medicare patients who saw Dr. Koubeissi in 2024. The largest group is 65 to 74, with 38 patients. 71% of them have high blood pressure, and 65% have high cholesterol. 60% are also on Medicaid. Their average risk score is 2.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Koubeissi's median patient age at 54, with 57% women.

In 2024, Dr. Koubeissi wrote 141 Medicare Part D claims for 27 patients. 72% of them were for generic drugs. CMS names the drug for 83 of them, across 3 drugs with 11 or more claims each, at $47,207 in total drug cost. In 2023, CMS named 82 claims across 3 drugs.

Dr. Koubeissi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Koubeissi as offering telehealth.

Dmand AI links 115 papers to Dr. Koubeissi, published from 2008 to 2025. 2021 was the busiest year, with 7. The most frequent topics are Seizures, Electroencephalography and Epilepsy. Dr. Koubeissi has published most often in Epilepsy Behav. Dr. Koubeissi's most frequent co-authors are Hai Chen, William D. Gaillard and Tobias Loddenkemper, MD.

CMS Open Payments shows 1,093 general payments to Dr. Koubeissi from 15 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 52% of the total. SK Life Science, Inc. paid the most, $272,466. It also lists 12 research payments totaling $1,788 in 2017.

Dmand AI lists 6 awards for Dr. Koubeissi, most recently Innovation Award in 2012.

Dr. Koubeissi graduated from American University of Beirut Faculty of Medicine in 1999. Dr. Koubeissi is a member of AES.

Dr. Koubeissi is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.